Gamma-glutamyltransferase and cancer incidence: The Ohsaki cohort study

Journal of Epidemiology

Volumn 22, Issue 2, 2012, Pages 144-150

  Tsuboya, Toru ^a   Kuriyama, Shinichi ^a   Nagai, Masato ^a   Hozawa, Atsushi ^a,b   Sugawara, Yumi ^a   Tomata, Yasutake ^a   Kakizaki, Masako ^a   Nishino, Yoshikazu ^a,c   Tsuji, Ichiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cancer incidence; Gamma glutamyltransferase; Ohsaki study; Population based; Prospective study

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; DRINKING BEHAVIOR; ENZYMOLOGY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASM; PROSPECTIVE STUDY;

ADULT; AGED; ALCOHOL DRINKING; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84862287194     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20110071     Document Type: Article

References (23)

1. Lee DH, Ha MH, Kam S, Chun B, Lee J, Song K, et al. A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol. 2006; 163:57-65.
2. Pompella A, Emdin M, Passino C, Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med. 2004;42:1085-91.
3. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004;38:535-9.
4. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47-95.
5. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci. 2001;947:271-92.
6. Hochwald SN, Harrison LE, Rose DM, Anderson M, Burt ME. Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst. 1996;88:193-7.
7. Franzini M, Corti A, Lorenzini E, Paolicchi A, Pompella A, De Cesare M, et al. Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. Eur J Cancer. 2006;42:2623-30.
8. Pompella A, Corti A, Paolicchi A, Giommarelli C, Zunino F. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol. 2007;7:360-6.
9. Pompella A, De Tata V, Paolicchi A, Zunino F. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol. 2006;71:231-8.
10. Strasak AM, Pfeiffer RM, Klenk J, Hilbe W, Oberaigner W, Gregory M, et al. Prospective study of the association of gammaglutamyltransferase with cancer incidence in women. Int J Cancer. 2008;123:1902-6.
11. Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, et al. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res. 2008;68:3970-7.
12. Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst. 2009;101:296-305.
13. Genkinger JM, Spiegelman D, Anderson KE, Bergkvist L, Bernstein L, van den Brandt PA, et al. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev. 2009;18:765-76.
14. Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study. J Natl Cancer Inst. 2010;102:1422-31.
15. Tramacere I, Scotti L, Jenab M, Bagnardi V, Bellocco R, Rota M, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer. 2010;126:1474-86.
16. Tsuji I, Nishino Y, Ohkubo T, Kuwahara A, Ogawa K,Watanabe Y, et al. A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. J Epidemiol. 1998;8:258-63.
17. Tsuji I, Kuwahara A, Nishino Y, Ohkubo T, Sasaki A, Hisamichi S. Medical cost for disability: a longitudinal observation of national health insurance beneficiaries in Japan. J Am Geriatr Soc. 1999;47:470-6.
18. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296:1255-65.
19. Naganuma T, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-Matsuda K, et al. Green tea consumption and hematologic malignancies in Japan: the Ohsaki study. Am J Epidemiol. 2009;170:730-8.
20. North, AB, South, CD. Cancer Incidence in Antarctica, 1998-2002. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al, editors. Cancer Incidence in Five Continents Vol. IX. IARC Scientific Publications No. 160. Lyon: IARC; 2007.
21. Szasz G. Methods of Enzymatic Analysis. 2nd ed. English ed. New York: Academic Press, Inc.; 1974. p. 717.
22. Szasz G. Reaction-rate method for gamma-glutamyltransferase activity in serum. Clin Chem. 1976;22:2051-5.
23. Ogawa K, Tsubono Y, Nishino Y, Watanabe Y, Ohkubo T, Watanabe T, et al. Validation of a food-frequency questionnaire for cohort studies in rural Japan. Public Health Nutr. 2003; 6:147